Curio Wealth’s West Pharmaceutical WST Stock Holding History

Curio Wealth’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$251	–	1171
2026 Q1	$251	Buy	+1	New	+$249	﹤0.01%	694

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Curio Wealth's WST Position: Q2 2026 in Review

Curio Wealth sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 1 share — an estimated $251 sold.

Curio Wealth first reported a position in WST in Q1 2026 and held it in 1 quarter. The position peaked at $251 in Q1 2026. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Curio Wealth reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Curio Wealth sold 1 West Pharmaceutical share in Q2 2026, an estimated $251.
Curio Wealth first reported a position in West Pharmaceutical in Q1 2026 and held it in 1 quarter.
Curio Wealth's West Pharmaceutical position peaked at $251 in Q1 2026.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.